Home / Market News / $GILD
benzinga Corporate Catalyst Impact 55/100 ● positive

B of A Securities Maintains Buy on Gilead Sciences, Raises Price Target to $172

Oct 20, 2026, 10:53 AM UTC · Primary ticker $GILD

B of A Securities analyst Tim Anderson reiterated a Buy rating on Gilead Sciences and increased its price target from $168 to $172. This indicates a continued positive outlook from the analyst, suggesting potential upside for the stock based on their valuation.

B of A Securities analyst Tim Anderson maintained a 'Buy' rating on Gilead Sciences (GILD) and raised the price target from $168 to $172. This action signals continued confidence in the company's future performance and valuation from a major investment bank. For traders, this could be seen as a positive short-term catalyst, potentially leading to increased buying interest as the new price target suggests an upside. Long-term implications include a reinforced positive sentiment around Gilead's fundamentals. The key opportunity for traders is to capitalize on any upward momentum following this analyst upgrade, while the risk lies in the possibility that the market may not fully react to the new price target or that other market factors could overshadow this news.

$GILD positive Price target increase and Buy rating maintained
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.